Encapsulated glycosylated paclitaxel liposomes (gPTX-L) conjugated with anti-CD44 antibodies enhance cytotoxicity efficiently in vitro and in vivo in human ovarian overexpressed CD44 cancer cell lines [152]. This evidence concerns the gene CD44 and cancer.